Neochem Bio Solutions Board of Directors

Get the latest insights into the leadership at Neochem Bio Solutions. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Dinesh Chopra Chairman & Non-Exe.Director
Mr. Swapnil Rameshbhai Makati Managing Director
Mr. Hemangini Swapnil Dathia Whole Time Director
Mr. Rajasekaran Guha Non Executive Director
Mr. Falgunbhai Prajapati Ind. Non-Executive Director
Mr. Shail Jayesh Shah Ind. Non-Executive Director

Neochem Bio Solutions Share price

NEOCHEM

00.0

0 (0.00%)
Last updated on 9 Dec, 2025 | 09:06 IST
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

0.00

52 Week High

0.00

The current prices are delayed, login to your account for live prices

Neochem Bio Solutions FAQs

The board at Neochem Bio Solutions consists of experienced professionals, including Mr. Dinesh Chopra , Mr. Swapnil Rameshbhai Makati , and others, overseeing the company’s strategic and corporate governance.

Directors at Neochem Bio Solutions are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Dinesh Chopra is the current chairman at Neochem Bio Solutions.

Executive directors at Neochem Bio Solutions are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Neochem Bio Solutions adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Neochem Bio Solutions, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.